Cribriform-positive morphology was associated with a 3.6-fold higher risk for metastasis in patients with prostate cancer, and radiotherapy with neoadjuvant androgen deprivation therapy (ADT) was ...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ...
Novartis today announced new data from PSMAddition demonstrating improved prostate-specific antigen (PSA) responses with ...
Impact of homologous recombination repair alterations (HRRalt) on survival outcomes of patients (Pts) with metastatic hormone-sensitive prostate cancer (mHSPC). Effects of emerin dysregulation on the ...
These results correspond to an 80% reduction in the risk of death among patients surviving beyond five years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results